Literature DB >> 32745731

Serum magnesium and burden of atrial and ventricular arrhythmias: The Atherosclerosis Risk in Communities (ARIC) Study.

Mary R Rooney1, Pamela L Lutsey2, Alvaro Alonso3, Elizabeth Selvin2, James S Pankow2, Kyle D Rudser4, Samuel C Dudley5, Lin Yee Chen6.   

Abstract

INTRODUCTION: Low serum magnesium (Mg) is associated with an increased incidence of atrial and ventricular arrhythmias. A richer phenotyping of arrhythmia indices, such as burden or frequency, may provide etiologic insights.
OBJECTIVES: To evaluate cross-sectional associations of serum Mg with burden of atrial arrhythmias [atrial fibrillation (AF), premature atrial contractions (PAC), supraventricular tachycardia (SVT)], and ventricular arrhythmias [premature ventricular contractions (PVC), non-sustained ventricular tachycardia (NSVT)] over 2-weeks of ECG monitoring.
METHODS: We included 2513 ARIC Study visit 6 (2016-2017) participants who wore the Zio XT Patch-a leadless, ambulatory ECG-monitor-for up to 2-weeks. Serum Mg was modeled categorically and continuously. AF burden was categorized as intermittent or continuous based on the percent of analyzable time spent in AF. Other arrhythmia burdens were defined by the average number of abnormal beats per day. Linear regression was used for continuous outcomes; logistic and multinomial regression were used for categorical outcomes.
RESULTS: Participants were mean ± SD age 79 ± 5 years, 58% were women and 25% black. Mean serum Mg was 0.82 ± 0.08 mmol/L and 19% had hypomagnesemia (<0.75 mmol/L). Serum Mg was inversely associated with PVC burden and continuous AF. The AF association was no longer statistically significant with further adjustment for traditional lifestyle risk factors, only the association with PVC burden remained significant. There were no associations between serum Mg and other arrhythmias examined.
CONCLUSIONS: In this community-based cohort of older adults, we found little evidence of independent cross-sectional associations between serum Mg and arrhythmia burden.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial arrhythmias; Continuous electrographic monitoring; Older adults; Serum magnesium; Ventricular arrhythmias

Mesh:

Substances:

Year:  2020        PMID: 32745731      PMCID: PMC7665977          DOI: 10.1016/j.jelectrocard.2020.07.008

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  37 in total

1.  Yield and consistency of arrhythmia detection with patch electrocardiographic monitoring: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Susan R Heckbert; Thomas R Austin; Paul N Jensen; James S Floyd; Bruce M Psaty; Elsayed Z Soliman; Richard A Kronmal
Journal:  J Electrocardiol       Date:  2018-07-30       Impact factor: 1.438

2.  Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort.

Authors:  W D Rosamond; A R Folsom; L E Chambless; C H Wang; P G McGovern; G Howard; L S Copper; E Shahar
Journal:  Stroke       Date:  1999-04       Impact factor: 7.914

3.  Hypomagnesemia and cardiovascular system.

Authors:  G Efstratiadis; M Sarigianni; I Gougourelas
Journal:  Hippokratia       Date:  2006-10       Impact factor: 0.471

Review 4.  Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart Association.

Authors:  Lin Y Chen; Mina K Chung; Larry A Allen; Michael Ezekowitz; Karen L Furie; Pamela McCabe; Peter A Noseworthy; Marco V Perez; Mintu P Turakhia
Journal:  Circulation       Date:  2018-04-16       Impact factor: 29.690

Review 5.  The role of magnesium in clinical biochemistry: an overview.

Authors:  M F Ryan
Journal:  Ann Clin Biochem       Date:  1991-01       Impact factor: 2.057

Review 6.  ECG patch monitors for assessment of cardiac rhythm abnormalities.

Authors:  S Suave Lobodzinski
Journal:  Prog Cardiovasc Dis       Date:  2013 Sep-Oct       Impact factor: 8.194

7.  Serum and dietary magnesium and incidence of atrial fibrillation in whites and in African Americans--Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Jeffrey R Misialek; Faye L Lopez; Pamela L Lutsey; Rachel R Huxley; James M Peacock; Lin Y Chen; Elsayed Z Soliman; Sunil K Agarwal; Alvaro Alonso
Journal:  Circ J       Date:  2012-10-06       Impact factor: 2.993

Review 8.  Intravenous magnesium for cardiac arrhythmias: jack of all trades.

Authors:  Kwok-Ming Ho
Journal:  Magnes Res       Date:  2008-03       Impact factor: 1.115

9.  Reactive oxygen species-targeted therapeutic interventions for atrial fibrillation.

Authors:  Ali A Sovari; Samuel C Dudley
Journal:  Front Physiol       Date:  2012-08-06       Impact factor: 4.566

Review 10.  Electrocardiographic patch devices and contemporary wireless cardiac monitoring.

Authors:  Erik Fung; Marjo-Riitta Järvelin; Rahul N Doshi; Jerold S Shinbane; Steven K Carlson; Luanda P Grazette; Philip M Chang; Rajbir S Sangha; Heikki V Huikuri; Nicholas S Peters
Journal:  Front Physiol       Date:  2015-05-27       Impact factor: 4.566

View more
  3 in total

1.  Association between hypomagnesemia and severity of primary hyperparathyroidism: a retrospective study.

Authors:  Ding Na; Guo Tao; Liu Shu-Ying; Wang Qin-Yi; Qu Xiao-Li; Li Yong-Fang; Ou Yang-Na; Sheng Zhi-Feng; Yang Yan-Yi
Journal:  BMC Endocr Disord       Date:  2021-08-20       Impact factor: 2.763

2.  Association between Serum Magnesium and Hemoglobin in Patients with Primary Hyperparathyroidism.

Authors:  Na Ding; Tao Guo; Shu-Ying Liu; Qin-Yi Wang; Xiao-Li Qu; Yong-Fang Li; Yang-Na Ou; Yan-Yi Yang; Zhi-Feng Sheng
Journal:  Int J Endocrinol       Date:  2021-11-27       Impact factor: 3.257

3.  Does Ionized Magnesium Offer a Different Perspective Exploring the Association between Magnesemia and Targeted Cardiovascular Risk Factors?

Authors:  Vanessa Gagliano; Fabian Schäffeler; Rosaria Del Giorno; Mario Bianchetti; Cesar Fabian Carvajal Canarte; José Joel Caballero Regueira; Luca Gabutti
Journal:  J Clin Med       Date:  2022-07-11       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.